REMEDi4ALL
@remedi4all.bsky.social
52 followers 16 following 110 posts
The European Platform for Medicines Repurposing. Funded by #HorizonEurope. remedi4all.org
Posts Media Videos Starter Packs
Pinned
remedi4all.bsky.social
REMEDi4ALL is a #HorizonEU research initiative to drive forward the repurposing of medicines in Europe. The project, has the potential to reduce times & costs of drug development, making drug repurposing the new normal.

👉 More here: remedi4all.org

#REMEDi4ALL #DrugRepurposing
remedi4all.bsky.social
💻 Day 2 at the REMEDi4ALL Hackathon – the scientific programme!

Participants are exploring and prioritising drug repurposing candidates for neurodevelopmental disorders, turning data into decisions and shaping target product profiles.

Next: integrating patient perspectives for real-world impact!
remedi4all.bsky.social
💊Kicking off the REMEDi4ALL #Hackathon! 14 early-career researchers have joined us in Barcelona to explore repurposing candidates for three neurodevelopmental disorders.

📹 Stay tuned to hear directly from our participants and organisers as the week unfolds!
remedi4all.bsky.social
💻 Upcoming webinar: IP Strategies for Repurposing
🗓️ Fri 21 Nov | 14:00-15:30 CET

Join REMEDi4ALL with Beacon for Rare Diseases, LifeArc & King’s College London to explore IP challenges, strategies & practical tips for drug repurposing.

🔗 Register here: https://loom.ly/bG6rhso
remedi4all.bsky.social
📄New publication from REMEDi4ALL. Researchers at FIMM have published in iScience on detecting spatial artefacts (systematic errors) in drug screening: key for advancing new and repurposed medicines.

🔗Our interview: https://loom.ly/UV5SWig
🔗Full publication: https://loom.ly/UV5SWig
remedi4all.bsky.social
👥 REMEDi4ALL joined our sister project REPO4EU at #RExPO25 in Barcelona for a programme on innovation in drug repurposing & systems medicine.

Read highlights from our session: patient engagement, training, new tools & collaboration 👉 https://loom.ly/k4uER7w
remedi4all.bsky.social
🔬 New REMEDi4ALL dataset!

Phospholipidosis, the abnormal build-up of lipids in cells, can distort drug screening results and slow development.

REMEDi4ALL has shared imaging data to improve understanding of this phenomenon and support drug repurposing research.

🔗 https://loom.ly/sKA5Hp4
remedi4all.bsky.social
🌍 REMEDi4ALL is LIVE at #RExPO25 in Barcelona!

Today we’re at Barcelona Biomedical Research Park for REPO4EU's annual conference, joining the community and taking the stage to discuss patient engagement, training, internationalisation and the REMEDi4ALL platform!
remedi4all.bsky.social
📣New opportunity with REMEDi4ALL!

The REMEDi4ALL Partnering Portal is now open – creating a pathway for repurposing projects to collaborate with REMEDi4ALL.

If you’re considering a proposal, we encourage you to first connect with the REMEDi4ALL Concierge.

More➡️ https://loom.ly/xs12IxA
remedi4all.bsky.social
On 11–12 September, the REMEDi4ALL consortium gathered in Ljubljana for our fourth General Assembly Meeting. Over 50 members came together to reflect on progress, share achievements, and set priorities for the final two years of the project.

Read more here➡️ https://loom.ly/jREI4bU
remedi4all.bsky.social
🎓New Digital Academy event!

Join REMEDi4ALL’s Digital Academy with King’s College & LifeArc for a webinar on IP Strategies for Repurposing. Learn how to protect discoveries, tackle regulatory issues & move findings closer to patients.

🗓️ 21 Nov, 14:00–15:30 CET
🔗 https://loom.ly/dsFZvjU
remedi4all.bsky.social
🙌 Thank you to all who joined the #REMEDi4ALL General Assembly in Ljubljana.

Our community’s dedication & expertise drive progress in #DrugRepurposing – working together to bring safe & effective drugs to more patients.

➡️ Updates: https://remedi4all.org/

#DrugRepurposing
remedi4all.bsky.social
🇸🇮 We’re live from Ljubljana for the #REMEDi4ALL General Assembly!

After 3️⃣ years of collaboration, we’re looking back on our achievements & shaping the next steps to accelerate #PatientCentred medicines repurposing in Europe, & beyond.

➡️ More here: https://remedi4all.org #DrugRepurposing
remedi4all.bsky.social
📢Got a proposal for a #RareDisease #ClinicalTrial? Join our associated partner @lifearc.bsky.social Webinar & learn how experts can support you from protocol design & regulatory navigation to #PatientEngagement & #DataManagement.

🗓8 Oct 2025
➡️Register: [email protected]
remedi4all.bsky.social
📣 REMEDi4ALL consortium partner Medicines for Europe, is looking for a Value Added Medicines Policy Manager with a passion for drug repurposing and interest in shaping policy to join their team in Brussels and lead their work within the REMEDi4ALL project!

Apply here➡️ https://loom.ly/9ARRjuI
remedi4all.bsky.social
REMEDi4ALL and #iDR25 have been featured in Forbes, highlighting case studies in malaria, MND, CVS and RRP, the role of adaptive trial designs and patient input, and the need for stronger US–EU collaboration in drug repurposing.

📖 https://loom.ly/iY05I1A
remedi4all.bsky.social
Curious about drug repurposing and its impact?

🎥 Our latest video explains how repurposing existing medicines can accelerate access to effective treatments, benefitting patients and healthcare systems worldwide.

Learn more 🌐➡️ www.remedi4all.org
remedi4all.bsky.social
📣 Funders of repurposing: planning a call for #DrugRepurposing research? Our Practical Guide gives you everything you need to get started, including real-world examples from the #REMEDi4ALL Funders Network.

➡️ Download: https://loom.ly/njyk7j0 #ResearchFunding
remedi4all.bsky.social
🔬 Looking to accelerate drug repurposing?

Explore the REMEDi4ALL in-silico Drug Repurposing catalogue: an open resource helping researchers find new uses for existing drugs with advanced computational tools.

Learn more:
📹 Guide: https://loom.ly/e0bBYjc
📄 Publication: https://loom.ly/F7KIRjM
remedi4all.bsky.social
Thanks to everyone who joined today’s webinar on AI-driven #DrugRepurposing clinical trials!

Together with Beacon for Rare Diseases & Cures Within Reach, we explored how funding can turn predictions into patient benefit—especially in #RareDiseases.

➡️ More: https://loom.ly/5zgrVP4
remedi4all.bsky.social
🚨 New from REMEDi4ALL: a framework to assess the value of repurposed medicines!

✅ Tailored to unique needs of drug repurposing
✅ Supports early funding justification
✅ Validated across multiple stakeholders
✅ Free and open-access

Explore here ⬇️
https://loom.ly/x6Y46o8
remedi4all.bsky.social
Join Beacon for Rare Diseases with Cures Within Reach & REMEDi4ALL on 31 July for a webinar exploring a new funding opportunity for AI-powered drug repurposing trials in rare diseases.

📅 31 July 🕞15:30 BST | 16:30 CEST
📝 Register: https://loom.ly/5zgrVP4
💡More info: https://loom.ly/QBMqtZY
remedi4all.bsky.social
💡At a recent REMEDi4ALL workshop, funders, observers and REMEDi4ALL consortium members explored our new framework for judging the project value of repurposed medicines.

📄Discover the resource here: https://loom.ly/x6Y46o8
👥Read about the workshop here: https://loom.ly/8LNkUGE
remedi4all.bsky.social
🧠 REMEDi4ALL joined Bionow’s 2025 Neuroscience Conference to discuss UK drug repurposing in neurological disorders!

We spoke on the “State of the Nation” panel and reconnected with key players including UCL, Alzheimer’s UK & Serenatis Bio.

More here ➡️ https://loom.ly/0N6y7IM
remedi4all.bsky.social
Want to revisit some of the #iDR25 Conference sessions? All resources are now available online for attendees, including:

✅delegate list
✅session recordings
✅ session slides
✅ posters presented
✅ articles, video highlights, photo gallery and more!

👉 https://loom.ly/_xSviOI
remedi4all.bsky.social
📢 REMEDi4ALL SOPs now on Zenodo!

Explore our first 12 SOPs supporting best practices in drug repurposing, from in silico workflows to FAIR data & phospholipidosis assays.

🔗 https://loom.ly/TuB6ihg

#DrugRepurposing #OpenScience #REMEDi4ALL